Evidence map›Paper›PMID 36398212›Full record

ArticleAmerican journal of translational research2022

Ghrelin alleviates depression-like behaviour in rats subjected to high-fat diet and diurnal rhythm disturbance.

Ganesh R Pawar, Yogeeta O Agrawal, Kartik T Nakhate, Chandragouda R Patil, Charu Sharma, Shreesh Ojha, Umesh B Mahajan, Sameer N Goyal

Open access · greenAbstract read
In one paragraph

Article in American journal of translational research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Ganesh R PawarDepartment of Pharmacology, R. C. Patel Institute of Pharmaceutical Education and Research Shirpur 425405, Maharashtra, India.
Yogeeta O AgrawalShri Vile Parle Kelavani Mandal's Institute of Pharmacy Dhule 424001, Maharashtra, India.
Kartik T NakhateShri Vile Parle Kelavani Mandal's Institute of Pharmacy Dhule 424001, Maharashtra, India.
Chandragouda R PatilDepartment of Pharmacology, R. C. Patel Institute of Pharmaceutical Education and Research Shirpur 425405, Maharashtra, India.
Charu SharmaDepartment of Internal Medicine, College of Medicine and Health Sciences, United Arab Emirates University Al-Ain P.O. Box 15551, Abu Dhabi, United Arab Emirates.
Shreesh OjhaDepartment of Pharmacology and Therapeutics, College of Medicine and Health Sciences, P.O. Box 15551, United Arab Emirates University Al Ain, United Arab Emirates.
Umesh B MahajanDepartment of Pharmacology, R. C. Patel Institute of Pharmaceutical Education and Research Shirpur 425405, Maharashtra, India.
Sameer N GoyalDepartment of Pharmacology, R. C. Patel Institute of Pharmaceutical Education and Research Shirpur 425405, Maharashtra, India.
Shri Vile Parle Kelavani Mandal · INUnited Arab Emirates University · AE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesIn the era of globalization, a sedentary lifestyle is highly linked with obesity and neurobehavioral complications such as depression. While depression is associated with dopamine dysfunction in the ventral tegmental area (VTA), ghrelin enhances the dopaminergic activity in the VTA. Therefore, the present study aimed to assess the effect of ghrelin on depression-like behaviour in rats subjected to a high-fat diet (HFD) and disturbed diurnal rhythm (DDR) for 45 days.

methodsThe neurobehavioral deficits resulting from HFD and DDR in rats, and the behaviour modulation by intra-VTA administration of ghrelin, alone or in combination with ghrelin receptor antagonist were confirmed by evaluation of behavioural parameters in the elevated plus-maze, forced swim test, open field test, and rotarod assessment. Further, the levels of pro-inflammatory cytokines such as tumor necrosis factor-α (TNF-α), interleukin-1β (IL-1β) and IL-6, oxidative stress marker malondialdehyde (MDA), and antioxidants enzymes like superoxide dismutase (SOD), reduced glutathione (GSH), and catalase (CAT) were measured.

resultsThe levels of TNF-α, IL-1β, IL-6, and MDA were increased in the brain of HFD and DDR exposed rats, while that of SOD, GSH, and CAT were reduced. Intra-VTA ghrelin administration from day 41-45 to the HFD and DDR exposed rats improved cognitive behaviour and physical activity confirming the antidepressant effect. Moreover, ghrelin restored the levels of SOD, GSH and CAT efficiently, and reduced that of MDA, TNF-α, IL-1β and IL-6, which signifies its protective effect.

conclusionOverall, this study confirmed the ameliorative effect of ghrelin in HFD- and DDR-induced depression-like behaviour.

Indexed as

cytokinesdepressiondiurnal rhythm disturbanceghrelinHigh-fat diet

Identifiers

PMID36398212
PMCPMC9641471
OpenAlexW4309412192

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.